Story · Medicine & Biotech
FDA Rejects Promising Cancer Drug Developed in China
1 outlet · first reported by MedPage Today on
(MedPage Today) -- The FDA declined to approve a closely watched drug developed in China for an indication in non-small cell lung cancer (NSCLC), drugmaker Summit Therapeutics announced, though the investigational bispecific antibody could soon... (MedPage Today)
Coverage, in order
-
FDA Rejects Promising Cancer Drug Developed in China(MedPage Today) -- The FDA declined to approve a closely watched drug developed in China for an indication in non-small cell lung cancer (NSCLC), drugmaker Summit Therapeutics announced, though the investigational bispecific antibody could soon...
Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.